Answers are grounded in this paper and cite their sources.
• Endometrial stromal sarcoma can metastasize to the lungs years after hysterectomy. • Bilateral multiple pulmonary metastases from ESS are extremely rare. • Complete resection via VATS achieved in a patient with bilateral lung lesions. • Five years of adjuvant progestin therapy followed by cessation due to subarachnoid. • hemorrhage. Eight-year disease-free survival after metastasectomy without recurrence. Low-grade endometrial stromal sarcoma (LG-ESS) is a rare uterine malignancy prone to late recurrence and distant metastasis, most commonly to the lungs. Bilateral multiple pulmonary metastases are exceedingly uncommon, and optimal management remains unclear. A 51-year-old woman underwent total abdominal hysterectomy for LG-ESS at age 43. Eight years later, routine chest radiography revealed multiple bilateral pulmonary nodules. Computed tomography showed three well-circumscribed nodules (7–9 mm) in the left S4, left S8, and right S8 segments. Positron emission tomography showed minimal fluorodeoxyglucose uptake. Bilateral video-assisted thoracoscopic wedge resections were performed, achieving complete removal of all lesions. Histopathology confirmed metastatic LG-ESS (CD10/ER/PR positive). The patient received oral medroxyprogesterone acetate for five years. The therapy was discontinued following subarachnoid hemorrhage due to a ruptured posterior-circulation intracranial aneurysm and treated by surgical clipping; she has no residual neurological deficits. She remains disease-free a total of eight years after metastasectomy. Complete resection of bilateral multiple pulmonary metastases from LG-ESS, combined with hormonal therapy, can achieve durable long-term disease control in carefully selected patients.
No takes yet. Share an insight, caveat, or question.
Sekine et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: